Professor Ranjit Manchanda
Professor of Gynaecological Oncology and Consultant Gynaecological Oncologist, Wolfson Institute of Population Health, Queen Mary University of London &
Barts Health NHS Trust, UK
Ranjit Manchanda is a Professor at Wolfson Institute of Population Health (WIPH), Queen Mary University of London (QMUL); Consultant Gynaecological Oncologist at Barts Health NHS Trust, London; and Honorary Professor Department of Health Services Research, London School of Hygiene & Tropical Medicine.
His research interests are focused around Targeted Precision Prevention. This includes population-based germline testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, stratification, and targeted screening & cancer prevention. He has a keen research interest in health economic issues related to these areas. He is Principal Investigator on the PROTECTOR trial, PROMISE Pilot study, GCaPPS trial, RRESDO, SIGNPOST, DETECT and UKCOGS studies.
He was awarded an NHS Innovation Accelerator (NIA) Fellowship for Population Genetic Testing (2019). He is a recipient of the RCOG Blair Bell award (2018); Dr Shyam Agarwal Memorial Oration award (2019); Helen Harris Memorial Trust travelling Fellowship; NIHR Clinical Lecturer Fellowship and ICMR Fellowship awards.
He co-Leads the Cancer Prevention Unit and is Director Graduate Studies at WIPH, QMUL. He is the Specialty Research Lead for Gynaecological Cancer, NIHR North Thames CRN. He leads the high-risk women’s Precision Prevention Clinic at Barts Health and chairs the London Cancer High risk Gynaecological Cancer MDT.
He is the Integrated Academic Training Programme Director, London Specialty School of Obstetrics & Gynaecology, Health Education England, & Lead for the RCOG Advanced Professional Module (APM) in Clinical Research for London. He is a member of number of other advisory bodies and oversight committees. He has led a number of training initiatives in Gynaecological Oncology across Europe, has served as President of the European Network of Young Gynaecological Oncologists (ENYGO) and member of the European Society of Gynaecological Oncology (ESGO) Council from 2011-2013.